Floatz logo

Therapeutic Asset Ratings

9,928 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
bt-007 cd7 car-t cells
T-Lymphoblastic Lymphoma
Bioceltech Therapeutics, Ltd.P1CC (43)
BTK-IN-24
Marginal Zone Lymphoma
Nurix Therapeutics, Inc.P1CC (43)
BTK-IN-24
Primary Central Nervous System Lymphoma
Nurix Therapeutics, Inc.P1CC (43)
BTK-IN-24
Central Nervous System Non-Hodgkin Lymphoma
Nurix Therapeutics, Inc.P1CC (43)
BTK-IN-24
Waldenstrom Macroglobulinemia
Nurix Therapeutics, Inc.P1CC (43)
Budigalimab
Squamous Cell Carcinoma
AbbVieP1CC (43)
Budigalimab
Gastroesophageal Cancer
AbbVieP1CC (43)
Budigalimab
Ovarian Serous Adenocarcinoma
AbbVieP1CC (43)
BUSULFANUM
Plasmablastic Lymphoma
City of Hope Medical CenterP1CC (43)
BUSULFANUM
Primary Effusion Lymphoma
City of Hope Medical CenterP1CC (43)
Bxcl701
Myelodysplastic Syndrome With Excess Blasts-2
Eric Stephen Winer, MDP1CC (43)
c105
Breast Carcinoma
University of WashingtonP1CC (43)
c-1101
Radiculopathy
Consano BioP1CC (43)
c134
Anaplastic Astrocytoma
James Markert, MDP1CC (43)
c134
Astrocytic Tumor
James Markert, MDP1CC (43)
c134
Brain Glioblastoma
University of Alabama at BirminghamP1CC (43)
c134
Gliosarcoma
James Markert, MDP1CC (43)
c134
Malignant Glioma
University of Alabama at BirminghamP1CC (43)
c402-cd19-car
Diffuse Large B-Cell Lymphoma
Shanghai Exuma Biotechnology Ltd.P1CC (43)
c402-cd19-car
Follicular Lymphoma
Shanghai Exuma Biotechnology Ltd.P1CC (43)
c402-cd19-car
High Grade B-Cell Lymphoma
Shanghai Exuma Biotechnology Ltd.P1CC (43)
c402-cd19-car
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
Shanghai Exuma Biotechnology Ltd.P1CC (43)
c402-cd19-car
Primary Mediastinal Large B-Cell Lymphoma
Shanghai Exuma Biotechnology Ltd.P1CC (43)
c5252
Brain Glioblastoma
ImmVira Pharma Co. LtdP1CC (43)
c7r.cd30.car-ebvst cells
ALK-Negative Anaplastic Large Cell Lymphoma
Baylor College of MedicineP1CC (43)
Showing 1376 to 1400 of 9,928 assets
PreviousPage 56 of 398Next